ICI 89406 is a selective beta-adrenoceptor antagonist, chemically described as a phenylurea derivative. It is utilized in pharmacological research to investigate beta-adrenergic signaling pathways, employed in both in vitro receptor binding assays and in vivo studies related to cardiovascular function.